Petros Pharmaceuticals, Inc. Total Liabilities and Equity
Petros Pharmaceuticals, Inc. (PTPI) had Total Liabilities and Equity of $3.55 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $3.55M.
- 2026-03-31: Liabilities and Equity $4.39M.
- 2025-12-31: Liabilities and Equity $5.16M.
- 2025-09-30: Liabilities and Equity $6.13M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $3.55M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $4.39M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $5.16M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $6.13M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $7.40M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $17.61M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $10.64M 10-K · filed 2026-04-15 |
| 2024-09-30 | $20.69M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $25.17M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $30.31M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $33.80M 10-K · filed 2025-03-31 |
| 2023-09-30 | $38.91M 10-Q · filed 2023-11-15 |
| 2023-06-30 | $28.73M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $30.57M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $32.42M 10-K · filed 2024-04-01 |
| 2022-09-30 | $37.70M 10-Q/A · filed 2022-11-15 |
| 2022-06-30 | $51.05M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $55.86M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $67.39M 10-K · filed 2023-03-31 |
| 2021-09-30 | $52.04M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $56.67M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $66.15M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $69.85M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |